Skip to content
10-Q

Quarterly Report

EMMAUS LIFE SCIENCES, INC.

0001564590-19-019118

← back to feed
Filed
May 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 10, 2019 36.05M sh
Capex Q1 2019 · Mar 31, 2019 $16K
Capex restated Q1 2019 · Mar 31, 2018 $15K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$1.28M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$615K
Cash And Equivalents Q1 2019 · Mar 31, 2019 $15.31M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $17.08M
Stockholders Equity Q1 2019 · Mar 31, 2019 −$24.55M
Stockholders Equity Q1 2019 · Dec 31, 2018 −$15.8M
Current Liabilities Q1 2019 · Mar 31, 2019 $53.49M
Current Liabilities Q1 2019 · Dec 31, 2018 $37.53M
Total Liabilities Q1 2019 · Mar 31, 2019 $95.36M
Total Liabilities Q1 2019 · Dec 31, 2018 $90.45M
Current Assets Q1 2019 · Mar 31, 2019 $66.81M
Current Assets Q1 2019 · Dec 31, 2018 $73.46M
Total Assets Q1 2019 · Mar 31, 2019 $70.74M
Total Assets Q1 2019 · Dec 31, 2018 $74.56M
Eps Basic Q1 2019 · Mar 31, 2019 −$0.40
Eps Basic Q1 2019 · Mar 31, 2018 −$0.17
Sga Expense Q1 2019 · Mar 31, 2019 $3.68M
Sga Expense restated Q1 2019 · Mar 31, 2018 $3.81M
Rd Expense Q1 2019 · Mar 31, 2019 $513K
Rd Expense restated Q1 2019 · Mar 31, 2018 $411K
Net Income Q1 2019 · Mar 31, 2019 −$14.17M
Net Income restated Q1 2019 · Mar 31, 2018 −$6.1M
Operating Income Q1 2019 · Mar 31, 2019 −$572K
Operating Income restated Q1 2019 · Mar 31, 2018 −$4.44M
Gross Profit Q1 2019 · Mar 31, 2019 $5.11M
Gross Profit restated Q1 2019 · Mar 31, 2018 $647K
Cost Of Revenue Q1 2019 · Mar 31, 2019 $200K
Cost Of Revenue restated Q1 2019 · Mar 31, 2018 $134K
Revenue Q1 2019 · Mar 31, 2019 $5.31M
Revenue Q1 2019 · Mar 31, 2018 $781K